Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections

類似資料

• An Adaptive Randomized Trial of an Intermittent Dosing Schedule of Aerosolized Ribavirin in Patients With Cancer and Respiratory Syncytial Virus Infection
  著者:: Chemaly, Roy F., 等
  出版事項: (2012)
• Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections
  著者:: Shah, Dimpy P., 等
  出版事項: (2014)
• Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients
  著者:: Foolad, Farnaz, 等
  出版事項: (2019)
• Use of Oral Ribavirin for the Treatment of RSV Infections in Hematopoietic Cell Transplant (HCT) Recipients
  著者:: Foolad, Farnaz, 等
  出版事項: (2017)
• Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation
  著者:: Mehta, Rohtesh S., 等
  出版事項: (2016)